Serum afamin concentrations were increased in patients with prediabetes and T2D compared to lean healthy controls (p<0.001, Figure 1A), and in patients with prediabetes compared to individuals with obesity (p<0.05, Figure 1A). This evidence concerns the gene AFM and type 2 diabetes mellitus.